Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
SAN DIEGO--(BUSINESS WIRE)--Nov 9, 2023--
Source: bdtonline.com
Stay updated with breaking news from Bio Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO--(BUSINESS WIRE)--Nov 9, 2023--
09.08.2022 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial ...
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update - Seralutinib Phase 2 TORREY Study on track for topline readout in second half of... | August 9, 2022